Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021.

IF 9.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL EClinicalMedicine Pub Date : 2024-09-05 eCollection Date: 2024-09-01 DOI:10.1016/j.eclinm.2024.102804
Ziyu Kuang, Jiaxi Wang, Kexin Liu, Jingyuan Wu, Yuansha Ge, Guanghui Zhu, Luchang Cao, Xinyi Ma, Jie Li
{"title":"Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021.","authors":"Ziyu Kuang, Jiaxi Wang, Kexin Liu, Jingyuan Wu, Yuansha Ge, Guanghui Zhu, Luchang Cao, Xinyi Ma, Jie Li","doi":"10.1016/j.eclinm.2024.102804","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Studies from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021 can guide screening and prevention strategies for tracheal, bronchus, and lung (TBL) cancer. We aim to provide global, regional, and national estimates of the TBL cancer burden and its attributable risk from 1990 to 2021, including during the coronavirus disease 2019 (COVID-19) pandemic.</p><p><strong>Methods: </strong>Incidence, age-standardised incidence rate (ASIR), deaths, age-standardised mortality rate (ASMR), disability-adjusted life years (DALYs), age-standardised rate of DALYs (ASDR), and the burden due to risk factors associated with TBL cancer were analysed from 1990 to 2021. Trends in ASIR, ASMR, and ASDR of TBL cancer during the COVID-19 pandemic (2019-2021) were also determined. All statistical analyses were performed using Join-point software (version 4.9.1.0).</p><p><strong>Findings: </strong>Between 1990 and 2021, the global incidence, deaths, and DALYs of TBL cancer to varying degrees. However, the ASIR (Average Annual Percent Change [AAPC], -0.3 [-0.4 to -0.2]), ASMR (AAPC, -0.5 [-0.7 to -0.4]), and ASDR (AAPC, -0.9 [-1.0 to -0.7]) all showed a decreasing trend. However, the ASIR, ASMR, and ASDR of TBL cancer in males all showed a decreasing trend from 1990 to 2021. In contrast, the ASIR and ASMR of TBL cancer in females showed an increasing trend, while the ASDR showed a relatively stable trend. During the COVID-19 pandemic, the trends for ASIR, ASMR, and ASDR remained stable across both sexes combined, females, males, five socio-demographic index (SDI) quintiles, and the 21 GBD regions. In 2021, smoking was a major risk factor for TBL cancer DALYs, but the attributable ASDR for smoking decreased from 1990 to 2021 in both sexes combined, as well as individually for males and females. Conversely, the attributable ASDR for secondhand smoke, high fasting plasma glucose and occupational exposure factors increased primarily among females. Furthermore, the attributable ASDR for ambient particulate matter pollution, household air pollution from solid fuels, and low-fruit diets increased primarily in regions with lower SDI quintiles from 1990 to 2021.</p><p><strong>Interpretation: </strong>The burden attributable to TBL cancer has increased in some populations from 1990 to 2021, highlighting the importance of implementing targeted measures to mitigate this trend. No significant change in the burden of TBL cancer was observed during the COVID-19 pandemic; however, post-COVID-19 rates still require further observation.</p><p><strong>Funding: </strong>This study was supported by National Key Research and Development Program of China (2023YFC3503300, 2023YFC3503305), and High Level Chinese Medical Hospital Promotion Project (HLCMHPP2023085, HLCMHPP2023001, HLCMHPP2023097).</p>","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"75 ","pages":"102804"},"PeriodicalIF":9.6000,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406099/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EClinicalMedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.eclinm.2024.102804","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Studies from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021 can guide screening and prevention strategies for tracheal, bronchus, and lung (TBL) cancer. We aim to provide global, regional, and national estimates of the TBL cancer burden and its attributable risk from 1990 to 2021, including during the coronavirus disease 2019 (COVID-19) pandemic.

Methods: Incidence, age-standardised incidence rate (ASIR), deaths, age-standardised mortality rate (ASMR), disability-adjusted life years (DALYs), age-standardised rate of DALYs (ASDR), and the burden due to risk factors associated with TBL cancer were analysed from 1990 to 2021. Trends in ASIR, ASMR, and ASDR of TBL cancer during the COVID-19 pandemic (2019-2021) were also determined. All statistical analyses were performed using Join-point software (version 4.9.1.0).

Findings: Between 1990 and 2021, the global incidence, deaths, and DALYs of TBL cancer to varying degrees. However, the ASIR (Average Annual Percent Change [AAPC], -0.3 [-0.4 to -0.2]), ASMR (AAPC, -0.5 [-0.7 to -0.4]), and ASDR (AAPC, -0.9 [-1.0 to -0.7]) all showed a decreasing trend. However, the ASIR, ASMR, and ASDR of TBL cancer in males all showed a decreasing trend from 1990 to 2021. In contrast, the ASIR and ASMR of TBL cancer in females showed an increasing trend, while the ASDR showed a relatively stable trend. During the COVID-19 pandemic, the trends for ASIR, ASMR, and ASDR remained stable across both sexes combined, females, males, five socio-demographic index (SDI) quintiles, and the 21 GBD regions. In 2021, smoking was a major risk factor for TBL cancer DALYs, but the attributable ASDR for smoking decreased from 1990 to 2021 in both sexes combined, as well as individually for males and females. Conversely, the attributable ASDR for secondhand smoke, high fasting plasma glucose and occupational exposure factors increased primarily among females. Furthermore, the attributable ASDR for ambient particulate matter pollution, household air pollution from solid fuels, and low-fruit diets increased primarily in regions with lower SDI quintiles from 1990 to 2021.

Interpretation: The burden attributable to TBL cancer has increased in some populations from 1990 to 2021, highlighting the importance of implementing targeted measures to mitigate this trend. No significant change in the burden of TBL cancer was observed during the COVID-19 pandemic; however, post-COVID-19 rates still require further observation.

Funding: This study was supported by National Key Research and Development Program of China (2023YFC3503300, 2023YFC3503305), and High Level Chinese Medical Hospital Promotion Project (HLCMHPP2023085, HLCMHPP2023001, HLCMHPP2023097).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
1990 至 2021 年全球、地区和国家气管、支气管和肺癌负担及其风险因素:2021 年全球疾病负担研究的发现。
背景:全球疾病负担、伤害和风险因素研究(GBD)2021的研究结果可以指导气管、支气管和肺(TBL)癌的筛查和预防策略。我们旨在提供 1990 年至 2021 年全球、地区和国家气管、支气管和肺癌负担及其可归因风险的估计值,包括 2019 年冠状病毒疾病(COVID-19)大流行期间的估计值:方法:分析了 1990 年至 2021 年期间的发病率、年龄标准化发病率(ASIR)、死亡率、年龄标准化死亡率(ASMR)、残疾调整生命年(DALYs)、残疾调整生命年年龄标准化率(ASDR)以及与 TBL 癌症相关的风险因素造成的负担。此外,还确定了 COVID-19 大流行期间(2019-2021 年)TBL 癌的 ASIR、ASMR 和 ASDR 的趋势。所有统计分析均使用 Join-point 软件(4.9.1.0 版)进行:结果:1990 年至 2021 年期间,全球 TBL 癌症的发病率、死亡人数和 DALYs 均有不同程度的下降。然而,ASIR(年均百分比变化[AAPC],-0.3 [-0.4 至 -0.2])、ASMR(AAPC,-0.5 [-0.7 至 -0.4])和 ASDR(AAPC,-0.9 [-1.0 至 -0.7])均呈下降趋势。然而,从 1990 年到 2021 年,男性 TBL 癌的 ASIR、ASMR 和 ASDR 均呈下降趋势。相比之下,女性 TBL 癌的 ASIR 和 ASMR 呈上升趋势,而 ASDR 则呈相对稳定趋势。在COVID-19大流行期间,男女两性、女性、男性、五个社会人口指数(SDI)五分位数和21个GBD地区的ASIR、ASMR和ASDR的趋势保持稳定。2021 年,吸烟是造成 TBL 癌症残疾调整寿命年数的主要风险因素,但从 1990 年到 2021 年,男女两性吸烟的可归因 ASDR 均有所下降,男性和女性的可归因 ASDR 也分别有所下降。相反,二手烟、高空腹血浆葡萄糖和职业暴露因素的可归因 ASDR 主要在女性中增加。此外,从 1990 年到 2021 年,环境颗粒物污染、来自固体燃料的家庭空气污染和低水果膳食的可归因 ASDR 主要在 SDI 五分位数较低的地区增加:从 1990 年到 2021 年,某些人群因 TBL 癌症造成的负担有所增加,这凸显了实施有针对性的措施来缓解这一趋势的重要性。在 COVID-19 大流行期间,TBL 癌症负担没有发生重大变化;但是,COVID-19 后的发病率仍需进一步观察:本研究得到了国家重点研发计划(2023YFC3503300、2023YFC3503305)和高水平中医医院促进项目(HLCMHPP2023085、HLCMHPP2023001、HLCMHPP2023097)的资助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
EClinicalMedicine
EClinicalMedicine Medicine-Medicine (all)
CiteScore
18.90
自引率
1.30%
发文量
506
审稿时长
22 days
期刊介绍: eClinicalMedicine is a gold open-access clinical journal designed to support frontline health professionals in addressing the complex and rapid health transitions affecting societies globally. The journal aims to assist practitioners in overcoming healthcare challenges across diverse communities, spanning diagnosis, treatment, prevention, and health promotion. Integrating disciplines from various specialties and life stages, it seeks to enhance health systems as fundamental institutions within societies. With a forward-thinking approach, eClinicalMedicine aims to redefine the future of healthcare.
期刊最新文献
Effectiveness of strategies for implementing guideline-concordant care in low back pain: a systematic review and meta-analysis of randomised controlled trials. Reporting guidelines for randomised controlled trial reports of implantable neurostimulation devices: the CONSORT-iNeurostim extension. Child outcomes after prenatal exposure to platinum and taxane-based chemotherapy: an unplanned interim analysis of the international network on cancer, infertility, and pregnancy study. Real-world data: bridging the gap between clinical trials and practice. Erythema multiforme.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1